COMMUNIQUÉS West-GlobeNewswire

Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy
03/11/2025
Investor webcast to be held on Monday November 3, 2025 at 8:00 am EST HAYWARD, Calif., Nov. 02, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum